Deerfield Management’s Gilead Sciences GILD Stock Holding History

Deerfield Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,491,000	Closed	-$102M	–	528
2024 Q2	$102M	Buy	+1,491,000	New	+$99.5M	1.7%	18
2022 Q4	–	Sell	-1,537,539	Closed	-$94.9M	–	110
2022 Q3	$94.9M	Sell	1,537,539 -15,100	-1%	-$952K	1.89%	13
2022 Q2	$96M	Buy	1,552,639 +787,150	+103%	+$48.7M	1.98%	15
2022 Q1	$45.5M	Buy	+765,489	New	+$48.9M	1.02%	31
2017 Q3	–	Sell	-938,515	Closed	-$66.4M	–	96
2017 Q2	$66.4M	Sell	938,515 -264,485	-22%	-$17.6M	3.54%	4
2017 Q1	$81.7M	Buy	+1,203,000	New	+$84.6M	3.15%	5
2013 Q3	–	Sell	-35,000	Closed	-$1.79M	–	121
2013 Q2	$1.79M	Buy	+35,000	New	+$1.82M	0.08%	94

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Deerfield Management's GILD Position: Q3 2024 in Review

Deerfield Management sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 1,491,000 shares — an estimated $102M sold.

Deerfield Management first reported a position in GILD in Q2 2013 and held it in 7 quarters. The position peaked at $102M in Q2 2024. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

Deerfield Management reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
Deerfield Management sold 1,491,000 Gilead Sciences shares in Q3 2024, an estimated $102M.
Deerfield Management first reported a position in Gilead Sciences in Q2 2013 and held it in 7 quarters.
Deerfield Management's Gilead Sciences position peaked at $102M in Q2 2024.
1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Deerfield Management's 13F filing for Q3 2024, filed 14 Nov 2024.